Call for Abstract

37th World Cancer Conference, will be organized around the theme “Innovations and Novel Approaches in Diagnosis and Treatment of different Cancers”

World Cancer 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in World Cancer 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Tumor Biology
  • Track 1-2Cancer Epigenetics
  • Track 1-3Oncogenes & Proto-oncogenes
  • Track 1-4Tumour Suppressor Genes
  • Track 2-1Cancer Stem Cells
  • Track 2-2Stem Cell Transplantation
  • Track 2-3Bone Marrow Transplantation
  • Track 2-4CSCs and Cancer Treatment
  • Track 3-1Breast Cancer, Gastrointestinal Cancer, Gynaecologic Cancers -Cervical Cancer, Uterus Cancer, Ovarian Cancer, Vulvar Cancer, Brain Cancer, Bone Cancer, Prostate Cancer, Lung Cancer, Lymphoma, Leukaemia, Liver Cancer, Blood Cancer, Eye Cancer, Skin Cancer
  • Track 4-1Diagnostic Biomarkers
  • Track 4-2Pharmacodynamics and pharmacokinetics
  • Track 4-3Prognosis, Screening and treatment predictions
  • Track 4-4Risk assessment, Diagnosis
  • Track 4-5Biomarkers in Cancer Medicine
  • Track 4-6Biomarkers in Medicine
  • Track 4-7Biomarkers in Cancer Research
  • Track 4-8Companion Biomarker
  • Track 4-9Predictive & Prognostic Biomarkers
  • Track 4-10Tumour Suppressors Biomarkers
  • Track 4-11Molecular cancer biomarkers
  • Track 5-1CAR T-Cell Therapy
  • Track 5-2Oncolytic viral therapies
  • Track 5-3Gene therapy
  • Track 5-4Adoptive T-Cell transfer
  • Track 5-5Oncoviruses
  • Track 5-6Therapeutic Cancer Vaccines
  • Track 5-7HPV & Hepatitis B vaccine
  • Track 5-8Personalised Cancer Vaccines
  • Track 5-9Clinical Trails
  • Track 6-1Cancer Microenvironment
  • Track 6-2Chemo Drugs
  • Track 6-3Stealth Nanoparticles and Tumor Penetrating Peptides
  • Track 6-4Vector/Host Interaction
  • Track 6-5New Nanomaterials
  • Track 6-6Imaging and Theranostics
  • Track 6-7Early Diagnosis and Imaging
  • Track 6-8Advances in Nanotechnology
  • Track 7-1Clinical Toxicology
  • Track 7-2Pharmacokinetics
  • Track 7-3Pharmacodynamics
  • Track 7-4Drug interactions
  • Track 7-5Cancer Drug Targets
  • Track 7-6Molecular Carcinogenesis
  • Track 7-7Biochemical Pharmacology
  • Track 7-8Clinical Pharmacology
  • Track 8-1Treatment strategies
  • Track 8-2Adverse effects
  • Track 8-3Limitations
  • Track 8-4Cancer Therapeutics, Novel and experimental approaches
  • Track 9-1Medical Oncology
  • Track 9-2Uro-Oncology
  • Track 9-3Neuro-oncology
  • Track 9-4Clinical Oncology
  • Track 9-5Hematologic Oncology
  • Track 9-6Paediatric Oncology
  • Track 9-7Gynaecologic Oncology
  • Track 9-8Radiation Oncology-Radiation Therapies & Techniques, Medical Imaging, Radiobiology, Nuclear Medicine, Radiation Physics, Curative Radiation Therapy
  • Track 9-9Surgical Oncology-Surgical Techniques, General & Gynaec-onco surgeries, Radical procedures, Surgical Biopsies, Reconstructive Surgery
  • Track 9-10Dermato Oncology
  • Track 10-1Physiology & Cancer History
  • Track 10-2Identifying Risk Factors
  • Track 10-3Cancer Genomics & Biologic Factors
  • Track 10-4Targeted Agents & Conventional Treatment
  • Track 10-5New Genotyping Technologies
  • Track 11-1Cancer Etiology
  • Track 11-2Health Disparities
  • Track 11-3Genetic and molecular epidemiology
  • Track 11-4Environmental Carcinogens
  • Track 11-5Gene-Environment Interactions
  • Track 11-6Cancer Risk Prediction
  • Track 12-1Radiation Therapy
  • Track 12-2Immunotherapy
  • Track 12-3Targeted Cancer Therapies and Treatment
  • Track 12-4Stem Cell Therapy
  • Track 12-5Cancer Surgery
  • Track 12-6Hormonal Therapy
  • Track 12-7Precision Medicine
  • Track 12-8Palliative Care & Treatment
  • Track 13-1Host-Tumour Relation
  • Track 13-2Cancer Immunosurveillance and Immunoediting
  • Track 13-3Clinical Cancer immunology
  • Track 13-4Cancer Antigens & Vaccines
  • Track 13-5Cellular Immunotherapy
  • Track 13-6Antibody Therapy
  • Track 13-7Cytokine Therapy
  • Track 13-8Combination & Combinatorial Ablation and Immunotherapies
  • Track 14-1Patient Assessment & Education
  • Track 14-2Management & Palliative Care
  • Track 14-3Assessing Physical & Emotional Status
  • Track 14-4Treatment Plans
  • Track 14-5Symptom Management
  • Track 14-6Supportive Care
  • Track 14-7Direct Patient Care
  • Track 15-1Aromatherapy
  • Track 15-2Ayurveda
  • Track 15-3Reflexology
  • Track 15-4Art & Music Therapy
  • Track 15-5Homeopathic Medicines
  • Track 15-6Naturopathy
  • Track 15-7Anti-Cancer Agents in Medicinal Chemistry
  • Track 15-8Acupuncture
  • Track 16-1Oncogenesis
  • Track 16-2Avoiding Risk Factors
  • Track 16-3Changing Lifestyle Choices
  • Track 16-4Preclinical & Clinical Research
  • Track 16-5Early Detection Research
  • Track 16-6Immunoprevention
  • Track 16-7Chemo preventive Measures
  • Track 17-1Nutrition and Supplements
  • Track 17-2Diet and exercise
  • Track 17-3Cancer and Environment